Neuronetics, Inc. (STIM)
1.42
-0.16
(-10.13%)
USD |
NASDAQ |
Feb 13, 16:00
1.46
+0.04
(+2.82%)
After-Hours: 20:00
Neuronetics Total Assets (Quarterly) : 145.46M for Sept. 30, 2025
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Celldex Therapeutics, Inc. | 648.44M |
| Plus Therapeutics, Inc. | 18.67M |
| Atossa Therapeutics, Inc. | 58.01M |
| Abeona Therapeutics, Inc. | 231.10M |
| Cell Source, Inc. | 0.2865M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 114.10M |
| Shareholders Equity (Quarterly) | 27.36M |
| Debt to Equity Ratio | 3.317 |
| Current Ratio | 2.242 |
| Net Debt Paydown Yield | -3.01% |